T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma

MLA

Francis J. Hornicek, et al. “T‐LAK Cell‐originated Protein Kinase (TOPK): An Emerging Prognostic Biomarker and Therapeutic Target in Osteosarcoma.” Molecular Oncology, vol. 15, June 2021, pp. 3721–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75647682d0b21b2d5d95553b6dc4c200&authtype=sso&custid=ns315887.

APA

Francis J. Hornicek, Ran Wei, Noah Federman, Pichaya Thanindratarn, Dylan C. Dean, Arun S. Singh, Scott D. Nelson, & Zhenfeng Duan. (2021). T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma. Molecular Oncology, 15, 3721–3737.

Chicago

Francis J. Hornicek, Ran Wei, Noah Federman, Pichaya Thanindratarn, Dylan C. Dean, Arun S. Singh, Scott D. Nelson, and Zhenfeng Duan. 2021. “T‐LAK Cell‐originated Protein Kinase (TOPK): An Emerging Prognostic Biomarker and Therapeutic Target in Osteosarcoma.” Molecular Oncology 15 (June): 3721–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75647682d0b21b2d5d95553b6dc4c200&authtype=sso&custid=ns315887.